INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/People & Leaders/John Brittas
Back to Newsroom
👤Key Figure Dossier

John Brittas

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

8 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Markets, IPOs & Wealth Just now (11:04 AM IST)

Flipkart Posts Record Single-Day Sales of $200 Million in Biggest-Ever Trading Day

Flipkart has recorded its highest-ever single-day sales, grossing about $200 million in what marks the strongest day in the Bangalore-based company’s history since its launch in 2007. The milestone underscores the scale of India’s online retail market and the enduring power of festive-season demand, even as competition and margin pressures remain intense across e-commerce.

By RDU Global Wire5 min read
National Governance & Policy11 Oct 2026, 11:16 PM IST

Left Parties Accuse Delhi Police of Turning Protest Into ‘War Zone’; MP Brittas Hospitalised After Detention

Left parties on Monday accused Delhi Police of using excessive force against protesters, alleging that the capital was turned into a “war zone” during the detention of opposition leaders and activists. CPI(M) general secretary M.A. Baby said police vans had been converted into “torture camps,” while party leaders claimed women were detained for hours inside mobile jails. Rajya Sabha MP John Brittas was hospitalised after being detained, intensifying the political fallout.

5 min readRead →
Markets, IPOs & Wealth15 Oct 2026, 03:42 AM IST

Johnson & Johnson Shares Sink as Profit Miss, MedTech Weakness and Litigation Costs Shake Investors

Johnson & Johnson shares fell as much as 6.8% after the healthcare giant reported a sharp drop in quarterly profit, even as it lifted its full-year earnings outlook. Investors focused on weaker-than-expected MedTech performance and litigation-related charges, which overshadowed revenue growth and an adjusted earnings beat. The reaction underscores how sensitive the stock remains to margin pressure and legal overhangs despite the company’s defensive profile.

5 min readRead →
Markets, IPOs & Wealth15 Oct 2026, 03:21 AM IST

Johnson & Johnson Shares Slide as Profit Miss, MedTech Weakness and Litigation Costs Shake Investors

Johnson & Johnson shares fell as much as 6.8% after the healthcare giant reported a sharp drop in quarterly profit, weaker-than-expected MedTech performance and litigation-related charges that overshadowed an otherwise improved full-year earnings outlook. Revenue growth and adjusted earnings beat Wall Street estimates, but investors focused on the quality of the beat and the pressure points beneath the headline numbers.

6 min readRead →
India Entertainment & Culture14 Oct 2026, 05:53 PM IST

‘Matchbox: The Movie’ Review: John Cena Keeps the Action Comedy Moving

‘Matchbox: The Movie’ leans on a familiar mix of friendship, international intrigue and tightly staged action to deliver a predictable but consistently watchable ride. John Cena anchors the film with physical ease and comic timing, helping it stay buoyant even when the plot follows well-worn genre paths.

5 min readRead →
Markets, IPOs & Wealth14 Oct 2026, 04:51 PM IST

Johnson & Johnson Shares Sink as Profit Miss, MedTech Weakness and Litigation Costs Weigh on Outlook

Johnson & Johnson shares fell as much as 6.8% after investors digested a sharp drop in quarterly profit, softer-than-expected MedTech performance and litigation-related charges, even as the company raised its full-year earnings outlook. Revenue growth and adjusted earnings beat estimates, but the market focused on margin pressure and the quality of the beat rather than the headline guidance upgrade.

5 min readRead →
Global Markets & Equities14 Oct 2026, 01:43 AM IST

Johnson & Johnson Shares Slip as Investors Zero In on MedTech Outlook Despite Earnings Beat

Johnson & Johnson reported stronger-than-expected earnings, but its shares fell as investors shifted attention away from the headline numbers and toward the company’s medical technology division. The reaction underscores a market that is increasingly focused on segment-level growth, margin durability, and the pace of recovery in higher-growth healthcare businesses.

4 min readRead →
Frontier AI & Machine Learning09 Oct 2026, 11:25 PM IST

Ferrari Chair John Elkann Backs AI, but Warns the Payoff May Lag the Spending

Ferrari chairman John Elkann struck an upbeat tone on artificial intelligence, dismissing fears of an imminent bubble while acknowledging that the technology’s investment cycle may run ahead of near-term revenue gains. His remarks reflect a broader debate across global markets: AI is drawing enormous capital, but the path to monetization remains uneven and uncertain.

5 min readRead →

👤 About this Entity

Political leaders, ministers, corporate executives, judges, athletes and creators. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside John Brittas: